OUR EXPERTISE

We’re a Bench-to-Market Life Science Provider

HEMEX is committed to changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support, either in-house or via our network of pre-qualified experts, laboratories, CMOs, warehouses, logistic partners and affiliates. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare.

Your journey from “green to gold”

Start-ups can enter the program at any stage.

We invest in selected life science start-ups that are part of the inQbator program, in cash and/or kind.

For scale up and close to market Start-ups; we are your trusted partner! We combine a series of professional services that are available to you in-house. Have a look at our pipeline of services.

learn more

DREAM

Your journey starts here. Ready to incorporate and not sure about the next steps? Come and see us, we offer an unbeatable one-stop-shop solution!

  • 1-5 founders
  • We give you some first advice for free
  • We help you apply for the Innosuisse coaching program
  • We discuss your financing options and show you how to get there
  • Our in-house notary and accountant will support you with incorporation and setting up your accounts
  • Our IP lawyers advise you on your patents and brands strategy

PLAN

Our lawyer and notary will help you draft all documents and guide you through the process of incorporation.

  • 2-5 first employees
  • You can join our incubator in Liestal (rent-a-desk or full-service virtual office)
  • We discuss with you the best way to get to market approval
  • We help you negotiate a license agreement with the university
  • We help you write a business and development plan
  • We help you find Seed financing
  • We help you with regulatory strategy for EMA and FDA

EXECUTE

Now is the time to put your plans into reality and continue with the product development. HEMEX will help you with all steps that are needed.

  • 5-10 employees
  • We help you with Series A financing
  • We set up your Quality Management System and perform (mock-)audits
  • We partner with you for non-dilutive grants
  • We support your product development with preclinical and clinical operations
  • We help you CE-mark your medical device or get positive CHMP/FDA opinion

SCALE

First sales! Profit is still a bit down the road, though. Scale up is needed, but growing pains are real. We’ll help you go international.

  • 10-50 employees
  • Obtain approval in your first market!
  • We help you with Series B financing
  • We help you develop an international (transfer) pricing strategy
  • We help you develop an approval and reimbursement strategy in the 7MM
  • We help you setting up licensing or co-marketing deals

PROFIT

Your business is sustainable now. Your “baby” has become an adolescent and it’s time to start thinking of letting go!

  • 50-200 employees
  • We help you complementing the founder team with internationally experienced C-level executives who can guide the company through the next stage
  • We help you with market access and insight services in order to boost sales
  • We help you find strategic partners and investors with merger and acquisition capabilities

EXIT

It’s time to reap the fruits of your hard work! We help you with the different options to cash in on your investment.

  • >200 employees
  • We help you implementing your exit strategies
  • Further financing via a co-development or co-marketing partner
  • Trade sale to a larger market player
  • Initial Public Offering

What our start-ups say

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Starting from our first meeting with Hemex, we have gained a lot of value from their life science experience and knowledge. We have received continuous support from Hemex that has brought Hi-D Imaging one step further towards our goals.

Dealing with HEMEX was a very pleasant experience. We felt very competently advised at all times and will be glad to use their services again in the future.

Hemex offers us great support on various levels thanks to their very good network of experts in different fields. We appreciate Hemex’s dedicated commitment in supporting our companies development.

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Starting from our first meeting with Hemex, we have gained a lot of value from their life science experience and knowledge. We have received continuous support from Hemex that brought Hi-D Imaging one step further towards our goals.

Dealing with HEMEX was a very pleasant experience. We felt very competently advised at all times and will be glad to use their services again in the future.

Hemex offers us great support on various levels thanks to their very good network of experts in different fields. We appreciate Hemex’s dedicated commitment in supporting our companies development.

AMT Medical develops a unique coronary bypass system. AMT’s technique enables the bypass surgery to be performed through small holes in the chest. This device has the potential to be the new standard, with lower costs for society, fewer complications, and a faster recovery for the patient.

Annaida Technologies logo

One in 10 couples experiences difficulties conceiving a child. Annaida’s patented NMR technology gives fertility doctors the ability to perform a fast, non-invasive and quantitative embryo screening, providing patients with an improved overall IVF experience.

Swiss startup Artidis Fundraising

The ARTIDISNet platform uses a nanomechanical sensor that captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue from biopsies in cancer patients in under three hours.

Swiss Startup Aspivix Logo Fundraising

ASPIVIX SA is a medical technology company specializing in Women’s Health, which has developed a flagship product called CAREVIX™. This technology is  proprietary vacuum & suction-based. It is used to reduce pain, eliminate bleeding, and tissue tear during gynecological procedures requiring uterus access.

BioReperia logo

BioReperia, based in Sweden and Switzerland, offers a highly precise, humanized zebrafish model to the pharmaceutical industry, to evaluate the safety and efficacy of oncology drug candidates in vivo, getting results as early as within a week.

haako breathe asthma app logo

Haako’s holistic asthma management solution Breathe helps parents of children with asthma. Allowing parents to track and better understand their child’s condition, they can make informed care decisions that achieve better patient outcome for children and less stress to parents.

Swiss Startup Emovo Logo Fundraising

Emovo Care SA has developed the world’s first portable hand orthosis to support care-at-home after a stroke, the Emovo Hand. This product provides a natural sensation of moving the hand to hemiparetic stroke patients to practice functional, comfortable, and intensive exercises directly at home. Emovo’s connected solution will enable to motivate and measure patients’ progress to maximize the outcome of care.

ender provides rapid and reliable testing kits for acute COVID–19 capable of diagnosing multiple samples at once and within just 30 minutes. These tests can be used in hospitals as well as right on-site.

 

Swiss startup GeneLook Fundraising

GeneLook allows patients suffering from rare diseases to access their DNA profile using their smartphone, using it for personalized healthcare and health alerts. In exchange, GeneLook’s business model will also give pharmaceutical companies access to this data to develop new therapies.

GeoHealthApp logo

geoHealthApp GmbH developed an App that has the potential to stop the spread of COVID19. An interactive map shows areas with high infection rates that can be evaded by the user. Based on anonymous smartphone location data and AI, users learn if they have been in contact with infected people during the last 14 days. The Beta Version has been launched in Germany, Switzerland, Austria, UK and USA.

HexagonFab’s team has developed a new generation of biosensors for rapid and highly sensitive analysis of biomolecules like antibodies, proteins, and small molecules. This award-winning technology, based on graphene nanomaterial, allows pharmaceutical researchers and production staff to monitor biomolecule quality directly at the production line, which offers a $1B market opportunity.

 

Swiss Startup Inura Medical Logo Fundraising

Inura Medical developed a urethral suppository with an approved pharmaceutical agent to help patients  who are suffering from two highly prevalent and disabling health disorders: overactive bladder (OAB) and nocturia.

Hi-D Imaging AG aims to revolutionize the cardiovascular sector by making personalized heart valve replacement therapy a reality. The world’s first AI-based pre-operational planning platform that assesses different heart valves for the patient‘s specific anatomy before the surgery. This technology increases the life quality of the patient and the success rate of the surgery.

Juvabis AG is a spin-off from the University of Zürich and ETH-Zürich, focusing on antimicrobial therapeutic drugs. Juvabis’ most advanced program is apramycin for infusion, a “best-in-class” antibiotic. Apramycin for infusion represents the most successful program within the pan-European ENABLE pipeline of the European Innovative Medicines Initiative.

 

LiVET develops and produces rapid molecular point-of-care diagnostic tests for the veterinary market. Based on LiVET’s proprietary platform technology, veterinarians can diagnose infectious diseases and parasites directly on-site within just 30 minutes. The test kits run on commercially available devices that enables the user to test up to 16 samples at once. This allows for immediate and specific treatment. The first test panel for respiratory diseases in horses includes Strangles, EHV 1+4 and Influenza and will be available in 2020.

Swiss Startup MOMM Diagnostics Logo Fundraising

MOMM Diagnostic’s patented technology is used to early detect a biomarker for pre-eclampsia (PE), a pregnancy disorder that can have devastating effects on the health of the mother and the unborn baby. Affecting 5-8% of all pregnancies, pre-eclampsia is a rapidly progressive and potentially deadly condition.

Opterion is improving the quality of life of Peritoneal Dialysis (PD) patients. They have developed a novel PD solution that is glucose-free and considerably decreases the metabolic and peritoneal challenge of diabetes patients.

 

PerioTrap Pharmaceuticals GmbH is developing a completely new concept for the treatment of periodontitis, one of the most widespread infectious diseases worldwide. PerioTrap aims to eradicate the root of the disease and to ultimately restore patient confidence.

 

PreComb Therapeutics AG is developing the first point-of-care solution for clinically relevant drug testing, influencing patient-derived 3D microtissues for drug development and precision medicine. With this technology the entire process of generating a high number of drug efficacy data can be fully automated, allowing the establishment of a clinical network and a scalable razor blade business model to finally guide therapeutic decisions.

Resistell logo

Resistell’s life-saving technology is based on the detection of movement caused by living bacterial cells and provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

Swiss Startup Scailyte Logo Fundraising

Scailyte’s multi-disciplinary team is applying a data-driven approach to discover novel biomarkers and develop a new generation of precision diagnostics based on single-cell data and AI.

Sedimentum AG is a healthcare and tech startup developing the first contactless solution for fall and emergency detection in healthcare. This technological protection ensures the physical safety of people who are on their own without compromising privacy.

Swiss Startup Sleepiz Logo Fundraising

Sleepiz’s diagnostic device uses millimeter wave technology, sensor fusion, and machine learning to measure vital signs in a contactless and medical grade manner at home, completely changing the way disorders like sleep apnea are diagnosed.

STIMIT develops a non-invasive medical device that enables ICU patients to breath by stimulating diaphragm contractions, therefore creating natural breath instead of pumping air into the lungs with a machine. With this new therapy, the breathing muscle remains active and strong.

 

OUR PARTNERS

At Hemex we are dedicated to helping startups succeed. We partner with exceptionally motivated experts from business and life sciences, providing a combined knowledge platform with a considerable potential for new businesses.

MEET THE TEAM

Healthcare Management Experts

Each of our associates can rely on several years of specialized experience in the Life Science industry. In order to support your project from its inception to a future exit, we cover a broad area of expertise, ranging from clinical, quality and regulatory operations to financial, legal and business development.

We have 3 Innosuisse Coaches in our group: 1 Lead Coach and 2 Special Coaches (Intellectual Property and Fundraising & Investor Relations), so we can offer you all the support you need under one roof.

Rafiq
Medical / Ra

Vanessa
Legal

Franziska
commercial

Samidha
clinical

Pascal
CEO

Vanja
Clinical

Arthur
Veterinary

Laurène
Clinical

Hans Zulliger Quality QP

Hans
Quality & QP

Yaozi
Communications

Juan
Digital Media

Werner
Board

Ivana
Digital Media

Paul
President

Dr. Philipp Marchand

Philipp
IP Consultant

Brigitte
IP Consultant

Dieter
Finance

Andreas
Business Coach

Mohamed
Clinical

Beatrix
PR

Vincenzo
Clinical

Kira
Clinical

Marilyn
Facility

Valentin
Sales Scale-up

Martin
coach

Stefan
Medical Innovation

Birgit
Market Insights

Kurt
Submissions

Virginia
Grants

João
Wearables expert

Pascal
QP

Office Manager / Personal Assistant

(HEMEX)

100% (m/f)

Location: Liestal, Switzerland

Candidate Profile

Requirements

  • Experience, preferably in a similar role, in an international company (ideally life science)
  • Strong interpersonal skills, maturity, persuasiveness, and a high level of discretion
  • Strong organizational skills with ability to multitask and independently set clear priorities
  • Accurate working style and hands-on “start-up” mentality
  • Excellent knowledge of MS Office tools (Word, Excel, Outlook, …)
  • Excellent language command in English and German. Additional languages, especially French or Italian, are a plus.
Responsibilities

Tasks

You will be the driving force who makes sure that the day-to-day operations of Hemex’s head office run smoothly:

  • Management of the office (organization of meetings, sending out communications, obtaining proposals from vendors, approval of expenses, supplier management, facility management, …)
  • Personal assistant to the CEO (handling e-mails, calls, calendar management, …)
  • Independently administer the human resources processes (recruitments, salary administration, holiday management, training activities…)
  • Support financial operations (interactions with invoicing & accounting)
  • General administrative tasks
  • Organization of travel arrangements and special events, interactions with visitors and clients.
Our Offer

HEMEX AG is committed to changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare.

Benefits

  • Join a diverse, multi-disciplinary, highly motivated and skilled team working on a variety of medical innovations
  • Office-based employment in Liestal (Switzerland), 7min by foot from Liestal SBB train station
  • Modern, inclusive, pleasant working environment in a fast-growing, dynamic organization
  • Ability to independently manage and develop your role and responsibilities
How to apply

If you meet the described profile, we look forward to receiving your CV in English, including supporting documents, by e-mail to Pascal Winnen at pascal.winnen@hemex.ch

Senior Regulatory Affairs Manager

(HEMEX)

MedTech/Pharma/Animal Health

100% (m/f)

Location: Liestal, Switzerland

Candidate Profile

The ideal candidate is an expert in regulatory affairs for pharmaceuticals and/or medical devices, and is willing to develop into an all-round specialist for regulatory affairs in various industries (including animal health, cosmetics, environmental topics, …). In addition the candidate must have:

  • University degree in Medicine, Pharmacy, Life Sciences, or related discipline;
  • At least 5 years’ Regulatory Affairs experience in EU or US, in a regulated industry (pharmaceuticals, biologics, medical devices);
  • Excellent knowledge of international regulatory standards and regulations in the areas of quality, safety, and efficacy in the EU/US/CH, other regions are a plus;
  • Team player with strong interpersonal skills, excellent communicator;
  • Maturity, persuasiveness, and a high level of discretion;
  • Strong organizational skills with ability to multitask and independently set clear priorities;
  • Excellent problem-solving “can do” capacity;
  • Efficient working style and hands-on start-up mentality;
  • Excellent knowledge of MS Office tools (Word, Excel, Outlook, …);
  • Based in Northwestern Switzerland region;
  • Excellent in written and verbal English is a must;
  • Fluent in either German, French and/or Italian; other languages are an added benefit.
Responsibilities

Tasks

The candidate will be the senior expert of our regulatory affairs group and will support expanding the team with additional regulatory affairs specialists as the company grows. In this role the candidate will:

  • Act as an all-round Subject Matter Expert regarding Regulatory Affairs (RA);
  • Provide interpretation of regulatory specific requirements to internal stakeholders;
  • Support our broad portfolio of start-ups with developing and implementing their regulatory strategy to accelerate market access;
  • Frequent communication with clients, regulatory authorities, ethics committee and institutional review boards in all continents;
  • Manage/coordinate various regulatory process, including CE-marking and Market Authorization Applications;
  • Support Sales Team with the preparation of cost proposals for clients;
  • Maintain and update existing regulatory authorizations and licenses;
  • Support with the maintenance of RA relevant regulations into Quality Management System procedures, and support during certification audits by regulatory bodies;
  • Work with the multidisciplinary team to keep our clients informed of regulatory requirements and emerging issues which may affect the registration/approval of their products;
  • Able and willing to mentor other staff members;
  • Be (financial) results oriented for Hemex and its clients.
Our Offer

HEMEX AG is committed to changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare.

Benefits:

  • Join a diverse, multi-disciplinary, highly motivated and skilled team working on a variety of medical innovations;
  • Office-based employment in Liestal (Switzerland), 7min by foot from Liestal SBB train station;
  • Modern, inclusive, pleasant working environment in a fast-growing, dynamic organization;
  • Ability to independently manage and develop your role and responsibilities.
How to apply

If you meet the described profile, we look forward to receiving your CV in English, including supporting documents, by e-mail to pascal.winnen@hemex.ch

Head of Smart Cancer Co-Diagnostics 

(OncoGenomX)

 

 

Candidate Profile

Through your experience in the field you have the unique opportunity to bring
innovative decision support solutions to life, resolving the unmet medical
need of matching drugs with individual tumors as a prerequisite for optimal
treatment outcome in all cancer patients. You will have the meaningful and
rewarding role of supporting and guiding the therapeutic decision making of oncologists across cancer areas, and to lay the foundations for the use of our
support solutions across geographies.

If you are a pioneer, a creative problem solver with a passion for genomics,
digital health and artificial intelligence, if you are driven by an entrepreneurial
mindset, a leader by example and a team player, then you may be the right
candidate we are looking for.

Responsabilities

Your responsibilities will include but are not limited to:
1 – Building a commercialization-ready molecular diagnostics laboratory in
Switzerland that can serve as a laboratory model across other countries (EU,
US), including all activities required to achieve accreditation, certification and
reimbursement of our services, and in compliance with the effective
international and country-specific regulations and guidelines for diagnostic
laboratories, medical devices and SaaS.
2- Supporting the building of a laboratory franchise across Europe and North
America.
3- Guiding the team’s direction, maintaining overview of planning, progress,
quality and budget.
4- Supporting the development of SCCD solutions for other cancer entities
and advancing them to commercialization readiness state, in collaboration
with our bioinformatics team and experts in the respective cancer fields
beyond-breast cancer.
5- Driving your team to make OncoGenomX a preferred diagnostics service
provider thanks to agile execution and effective partnering with oncologists,
cancer care practitioners and hospitals.
As the Head of Smart Cancer Co-Diagnostics you will be part of the
OncoGenomX leadership team, reporting to the CEO, with an option of
earning stock options and becoming a partner and/or member of the
founders group.

OncoGenomX's offer

OncoGenomX is a Swiss venture founded in October 2019. Our mission is to
empower oncologists to choose precisely those drugs that will most
effectively help their patient to achieve durable disease control. This is made
possible by:
1- A gene expression assay to determine the biological properties,
pharmacological sensitivities and clinical behavior of individual tumors.
2- The use of artificial intelligence to determine which cancer drugs are
appropriate for every tumor and which will permanently prevent disease
progression or metastasis.
3- Provision of collective treatment results from comparable patients, who
have completed treatment informed by Smart Cancer Co-Diagnostics (SCCD).
4- A machine learning routine to continuously learn from previous treatment
decisions and therapy results.
The Head of Smart Cancer Co-Diagnostics is an exciting opportunity to set up
our Swiss Smart Cancer Co-Diagnostics Laboratory. (S)he will be responsible
for the organization and management of the laboratory, the formation of a
team and the extension of our support services to cancer types beyond
breast cancer.
At the heart of this opportunity lies the development and validation of gene
expression assays run on nCounter and Illumina instrumentation, their
validation, certification and advancement to commercialization readiness.

How to apply

Contact: Wolfgang Hackl, Managing Director OncoGenomX.

E-Mail: hacklwo@oncogenomx.com

Regulatory Affairs Manager –  MedTech 
(Aspivix)

Renens (Lausanne Region), Switzerland

Candidate Profile

Soft skills:

  • Is an Excellent team player in a multicultural environment.
  • Shows a “Can-do-attitude” with agility.
  • Has passion for medical device.
  • Self-starter with ability to work independently under pressure and react quickly to changing priorities.
  • Is comfortable with decision process and decision making.

Experience & Education:

  • Master’s degree in life science, engineering or related fields.
  • Five (5) years minimum experience in regulatory affairs in MedTech.
  • Five (3) years minimum experience in regulatory affairs Management in MedTech.
  • Has proven track record in flawless registrations of medical devices in Europe and in the US. Medical device registration in APAC area is a plus Current knowledge of FDA 21 CFR part 820, Medical Device Regulation (MDR 2017 / 745), ISO 13485, ISO 14971, IEC 60601-1, IEC 62366, ISO 62364
  • Strong analytical, planning and organizational skills.
  • Strong interpersonal and communications skills (oral & written).
  • Experience in Start-up is a strong and determinant plus.
  • Fluency in English, German, or French is a plus.
Responsibilities

Core Responsibilities

  • Develops regulatory strategy for new products (Class I (s)(m)(r) and IIa) and implements plans to obtain FDA clearance/approvals, CE Mark and other foreign regulatory approvals.
  • Manages compliance to all relevant regulations, rules and standards for
    products and taking part in the conformity assessment procedures with
    coordination of all concerned departments.
  • Manages conformity assessment process and registration process for
    products including dossier preparation, submission to Competent Authorities or Notified Body, reviews of application and implementation.
  • Accompanying development projects, issuing development-accompanying
    and technical documentation for medical devices, revising already existing
    technical documentations. Maintains regulatory compliance of Technical Files.
  • Elaborates and reviews changes to existing Products, SOPs, Test Methods, Process Changes, Design Changes, Labeling/Labels, and Field issues to define the requirements for regulatory submissions and notifications.
  • Communication with responsible regulatory authorities (national/international) as well as with notified bodies.
  • Lead regulatory assessment of marketing claims and external communication.
  • Performs staff training on the topic of regulatory affairs.

Leadership Activities 

  • Foster the cooperation between diverse disciplines and functions managing a good balance between discussion, consensus, argumentation and decisiveness.
  • Lead others in the completion of project tasks and sub projects.
  • Smooth & facilitate the decision-making process.
  • Create a work environment that supports team effectiveness.
  • Provide feedback to team members.
  • Assist with integration of common tools and techniques.
  • Present to internal and external audiences, including board or investors.

Expertise and Problem-Solving Duties:

  • Identify resource requirements, cost, and time schedules. Develop an
    implementation plan, conduct risk assessments and develop contingency
    plans to accommodate unforeseen events.
  • As part of the management team, selects the specific action plans that will best meet the identified business objectives.
  • Be part of the vision and translate vision to project goals, roadmap and plans.
  • Analyze risks, suggest mitigation plans and develop alternatives to solutions.
  • Proactively anticipate and identify risk areas, alert stakeholders appropriately.
  • Able to identify and assess business risks for a given regulatory strategy.
Aspivix's offer

Aspivix is a growing MedTech aiming at innovating and advancing women’s care to enable an improved gynecological practice, empowering caregivers to deliver better patients’ experience. The company is headquartered in the Lausanne region, Switzerland. Our first device, currently in development, is a new
generation of non-invasive instrument for gynecological procedures, designed to reduce pain and eliminate bleeding for millions of women every year in the world. Are you ready to join a dynamic environment and an amazing team driven by the passion to improve Women’s care for millions of women?
If so, we can’t wait for you to join our team and bring your ideas and experience to sustainably advance the Women’s care.

We offer:
• A dynamic working environment as part of a start-up.
• Working in a MedTech startup which will make a difference in women’s health and with a true mission; at ASPIVIX, we innovate women’s care because we believe that women deserve gentler and more modern methods for procedures in gynecology.
• A possibility to form your own job and to contribute developing products with bigger potential. Your imagination and willingness are the limits.
• Co-operation with a nimble multinational team of brilliant and passionate colleagues.
• A chance to influence from the early beginning the course of a growing company.

How to apply

Should you want to contribute to a highly motivated and passionate team, with a lot of space for your own initiatives, send your complete application to : jobs@aspivix.com

Postdoctoral Scientist in In Vitro Diagnostic Image Capture and Analysis (deMello group at ETH)

100%, Zurich, temporary

Candidate Profile
The deMello group like to hear from computer scientists and/or imaging experts who are keen to gain expertise in bioengineering, IVDs and global health, and conversely from researchers who have experience in IVDs who are keen to move towards mHealth and computer science. Coding skills are essential. Previous experience writing code to automate high-throughput image capture and analysis, and in app development, are beneficial.
 
Candidates are expected to have obtained a PhD degree in a relevant science or engineering discipline. However, candidates will be judged on their overall experience, expertise and ambitions, rather than on their specific research discipline(s). Successful candidates will be part of an international research team and are expected to be highly motivated and passionate about science, engineering and global health.
Responsibilities

Job description

As a member of the deMello Group, you will work on the quantification of colorimetric data from microfluidics-based IVD devices, and on broader challenges in IVD development in the group. This represents an exciting opportunity to work at the interface of bioengineering and computer science, and the candidate will work in a diverse and dynamic group with an established interdisciplinary culture.
 

Responsabilities

  • Develop software that automates image capture, processing and data extraction from colorimetric IVDs
  • Integrate the software into an app with a user-friendly graphical user interface
  • Expertise in coding (essential)
  • Experience in software development (preferable)
  • Experience in IVD device development (preferable)
  • Experience in microfluidics engineering and imaging (preferable)
  • Work closely with our academic and industrial project partners to ensure the work progresses in line with the larger project objectives
  • Contribute to project management, including financial and time management
  • Present at internal project meetings and at international conferences
  • Write peer-reviewed publications

 

Project background

The availability of rapid IVD devices is critical for the control of infectious diseases. For example, the unavailability of widespread and rapid IVDs during the emergence of SARS-CoV-2 led to a severe lack of high-quality data in the early stages of that outbreak, which hindered critical time-sensitive interventions (e.g. test, trace, isolate). This rendered health agencies and governments powerless to stop COVID-19 becoming a global pandemic with terrible social and economic cost. In the deMello group, they have an established research activity on the development of colorimetric microfluidics-based IVD technologies targeting infectious disease. A key part of this work is in the development of the device–digital interface, where the output of an IVD is read and analyzed by a portable device (e.g. smartphone). To support the work in this area, the deMello group seeks a new team member who possess the relevant expertise and drive to make an impact in the diagnostics and global health fields.
deMello's offer

The deMello Group (Prof. Dr. Andrew deMello) in the Institute for Chemical and Bioengineering at ETH Zürich is searching for a postdoctoral researcher to work on image capture and analysis of colorimetric in vitro diagnostic (IVD) devices. The aim is to develop software and an associated smartphone app that is able to yield a reliable and robust quantitation of the target analyte, based on data extracted from captured images. They invite candidates with research interests in software development and image analysis, with a passion for improving global health through new technologies. The position is fixed-term at 12 months in the first instance, with a possibility for extension.

 

They offer:

  • A multicultural and multidisciplinary research environment
  • Attractive hiring conditions
  • Access to state of the art equipment and resources
  • Strong support in career progression

 

ETH Zurich is one of the world’s leading universities specialising in science and technology. They are renowned for their excellent education, cutting-edge fundamental research, and direct transfer of new knowledge into society. Over 30,000 people from more than 120 countries find their university to be a place that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging connections all over the world, they work together to develop solutions for the global challenges of today and tomorrow.

How to apply
Interested?

They look forward to receiving your online application with the following documents:

  • A cover letter detailing your motivation for applying, and how you meet the position requirements
  • A detailed CV including publication list and details of at least two references

Applications will be assessed continually, and a short list for interview will be drawn up on December 1st. Interviews will be held online in mid-December. We anticpate the chosen candidate starting the project in the first quarter of 2021. Please note that we exclusively accept applications submitted through our online application portal. Applications via email or postal services will not be considered.

Further information about the deMello group can be found on their website. Questions regarding the position are welcome, and should be directed to Dr Daniel Richards, daniel.richards@chem.ethz.ch (no applications).

 
 

LATEST NEWS

Our contact details

Office addresses

Hemex AG
Kasernenstrasse 30 | 4410 Liestal | Switzerland 

Hemex Germany GmbH
c/o Loeba Treuhand GmbH, Wallbrunnstr. 24 | 79539 Loerrach | Germany 

Hemex, LLC
The 5th Floor |  3801 Avalon Park East Blvd, Suite 200 | Orlando, FL 32828 | USA

Hemex APAC
c/o Launchpad APAC Pte. Ltd., 140 Robinson Road | #01 Crown At Robinson | Singapore 068907

E-Mail addresses

Hemex AG
info@hemex.ch
firstname.lastname@hemex.ch

Hemex Germany GmbH
info@hemex-germany.de
firstname.lastname@hemex-germany.de

Hemex, LLC
info@hemex-us.com
firstname.lastname@hemex-us.com

Telephone contact

Switzerland:

Mo-Fri 09:00-17:00 CET, our headquarters can be reached under (+41) 61-927-28-00.

Germany:

Mo-Fri 09:00-17:00 CET, our EU office can be reached under (+49) 1512-568-48-92.

Emergencies:

24/7/365 emergency phone numbers: 

(+41) 79-833-73-30 (Switzerland) 

(+49) 1512-568-48-92 (Germany)

Accommodation

Hotel Engel: 2 min. on foot (ask for preferred HEMEX rate)

Hotel Bad Bubendorf: 10 min. by car

Send us an e-mail